Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Diagnostic Pathology|April 29, 2025
Pathological and clinical insights into DICER1 hotspot mutated Sertoli-Leydig cell tumors: a comparative analysisZhuoyao Lyu, Yilin Liu, Jingci Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2023
Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic Analysis and a Predictive ModelJingci Chen, Liju Zong, Pengyan Wang, et al.
Cell Death and Differentiation|July 21, 2023
Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinomaHeng Ma, Xianlong Chen, Shengwei Mo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 1, 2015
Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinomaCuiping Wang, Yang Sun, Huanwen Wu, et al.
Endocrine|June 16, 2022
Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applicationsXinchao Ban, Shengwei Mo, Zhaohui Lu, et al.
Sleep Medicine|March 9, 2024
A population-based study exploring association of parasomnia symptoms with sleep onset delay among school-aged childrenRuoyu Lu, Rong Li, Yiting Chen, et al.
Sensors (Basel, Switzerland)|April 13, 2016
A Low Cost Compact Measurement System Constructed Using a Smart Electrochemical Sensor for the Real-Time Discrimination of Fruit RipeningLiuzheng Ma, Ling Wang, Ruipeng Chen, et al.
Oncotargets and Therapy|April 1, 2021
Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDACHuilin Shao, Yue Zhang, Jie Yan, et al.
Neuroendocrinology|August 4, 2021
Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese CohortXinchao Ban, Shengwei Mo, Zhaohui Lu, et al.
Oncotarget|April 12, 2014
CHIP is a novel tumor suppressor in pancreatic cancer through targeting EGFRTianxiao Wang, Jingxuan Yang, Jianwei Xu, et al.
Pageof 15